Sanofi (SNYNF)

OTC Markets OTCPK Currently unchanged in today's trading session

1 member of Congress has disclosed 1 trade in Sanofi (SNYNF) via STOCK Act filings. The most recent disclosure was a purchase by Peter Welch on 21 January 2015. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).

Sanofi is currently trading at $89.27, positioned at 33% of its 52-week range ($80.74 – $106.34).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$89.27
24h Change
0.00 (0.00%)
52 Week Range
$80.74$106.34
View on NASDAQ

Sanofi Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for SNYNF

Select to highlight on chart
1 transactions
Compliance: 0%
Peter Welch21 Jan 201516 May 2016PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$107.18B

Volume

311

Beta

0.29

P/E Ratio

9.88

Fundamentals

EPS

$9.04

Div. Yield

5.42%

Open

$92.65

Day Range

$89.27 – $92.65

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTC · USD
Country
FR
CEO
Belén Garijo López
IPO Date
2008-04-09

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus...

Earnings

Next Report

Q3 2026

30 Oct

EPS Est.

-

Rev. Est.

$15.2B

Days Until

53

Recent Quarters

Q2 202630 Jul
EPS$0.33
Q1 202623 Apr
EPS$1.54
Q4 202529 Jan
EPS$1.95
Q3 202524 Oct
EPS$2.69
Beat 63.0%
Q2 202531 Jul
EPS$3.76
Q1 202524 Apr
EPS$1.67
Miss 17.3%
Q4 202430 Jan
EPS$0.41
Miss 75.5%
Q3 202425 Oct
EPS$2.86
Beat 15.3%
Q2 202412 Sept
EPS$1.92
Beat 3.2%
Q1 202425 Apr
EPS$1.78
Beat 2.9%
Q4 20231 Feb
EPS$1.66
Miss 1.2%
Q3 202327 Oct
EPS$2.55
Miss 2.3%
Q2 202328 Jul
EPS$1.74
Beat 6.8%
Q1 202327 Apr
EPS$2.16
Beat 7.5%
Q4 20223 Feb
EPS$1.71
Beat 0.0%
Q3 202228 Oct
EPS$2.87
Beat 6.3%
Q2 202228 Jul
EPS$1.73
Beat 5.5%
Q1 202228 Apr
EPS$1.94
Beat 9.0%
Q4 20214 Feb
EPS$1.38
Beat 3.8%
Q3 202128 Oct
EPS$2.18
Beat 9.0%
Q2 202129 Jul
EPS$1.38
Beat 4.5%
Q1 202128 Apr
EPS$1.61
Beat 13.4%
Q4 20205 Feb
EPS$1.22
Beat 2.5%
Q3 202029 Oct
EPS$1.83
Beat 1.1%
Q2 202029 Jul
EPS$1.28
Beat 2.4%
Q1 202024 Apr
EPS$1.63
Beat 11.6%
Q4 20196 Feb
EPS$1.34
Beat 3.9%
Q3 201931 Oct
EPS$1.92
Beat 11.0%
Q2 201929 Jul
EPS$1.31
Beat 5.7%
Q1 201926 Apr
EPS$1.42
Beat 7.6%
Q4 20187 Feb
EPS$1.10
Beat 0.9%
Q3 201831 Oct
EPS$1.84
Beat 6.4%
Q2 201831 Jul
EPS$1.25
Beat 1.6%
Q1 201827 Apr
EPS$1.28
Beat 12.3%
Q4 20177 Feb
EPS$1.06
Miss 7.8%
Q3 20172 Nov
EPS$1.71
Miss 0.6%
Q2 201731 Jul
EPS$1.35
Beat 4.7%
Q1 201728 Apr
EPS$1.42
Beat 11.8%
Q4 20168 Feb
EPS$1.25
Beat 0.8%
Q3 201628 Oct
EPS$1.79
Beat 14.7%
Q2 201629 Jul
EPS$1.31
Beat 0.0%
Q1 201629 Apr
EPS$1.34
Beat 4.7%
Q4 20159 Feb
EPS$1.31
Beat 4.8%
Q3 201529 Oct
EPS$1.61
Beat 0.6%
Q2 201530 Jul
EPS$1.41
Beat 6.0%
Q1 201530 Apr
EPS$1.32
Beat 11.9%
Q4 20145 Feb
EPS$1.39
Beat 0.7%
Q3 201428 Oct
EPS$1.47
Beat 0.7%
Q2 201431 Jul
EPS$1.17
Beat 4.5%
Q1 201429 Apr
EPS$1.17
Miss 2.5%
Q4 20136 Feb
EPS$0.80
Miss 42.0%
Q2 20132 Aug
EPS$0.44
Q4 201231 Mar
EPS$0.97
Q4 20127 Mar
EPS$0.40
Q2 201230 Sept
EPS$1.50
Q2 201227 Jul
EPS$1.10
Q4 201131 Mar
EPS$1.84
Q4 20116 Mar
EPS$1.42
Q2 201130 Sept
EPS$2.04
Q2 201129 Jul
EPS$1.10
Q4 201031 Mar
EPS$1.32
Q4 20101 Mar
EPS$0.44
Q2 201030 Sept
EPS$1.68
Q2 201030 Jul
EPS$1.63
Q4 200931 Mar
EPS$1.77
Q4 200912 Mar
EPS$1.33
Q2 200930 Sept
EPS$1.59
Q2 200929 Jul
EPS$1.14
Q4 200831 Mar
EPS$1.62
Q4 20084 Mar
EPS$-1.17
Q2 200830 Sept
EPS$1.99
Q2 200831 Jul
EPS$1.40
Q4 200731 Mar
EPS$2.21
Q4 20077 Mar
EPS$1.30
Q2 200730 Sept
EPS$1.38
Q2 20072 Aug
EPS$1.34
Q1 20073 Apr
EPS$0.79
Q4 200631 Mar
EPS$1.31
Q2 200630 Sept
EPS$0.76
Q2 20062 Aug
EPS$0.82
Q4 200531 Mar
EPS$1.36
Q2 200530 Sept
EPS$0.64
Q2 200531 Aug
EPS$0.48
Q1 200511 Apr
EPS$-2.85
Q4 200431 Mar
EPS$1.37
Q2 200430 Sept
EPS$-4.20
Q2 200414 Sept
EPS$0.99
Q4 200331 Mar
EPS$0.94
Q4 200329 Jan
EPS$0.78
Q3 200327 Oct
EPS$1.09
Q1 200330 Jun
EPS$0.77
Q1 200323 Jun
EPS$0.56
Q4 200231 Mar
EPS$0.72
Q2 200230 Sept
EPS$0.63
Q1 200230 Jun
EPS$0.56

1 politician traded within 30 days

Dividends

Dividend History

6 May 2026
Amount $4.8422
13 May 2025
Amount $4.3806
13 May 2024
Amount $4.0500
30 May 2023
Amount $3.8130
6 May 2022
Amount $3.4930
5 May 2021
Amount $3.8239
4 May 2020
Amount $3.4418
9 May 2019
Amount $3.4189
11 May 2018
Amount $3.5920
16 May 2017
Amount $2.9600
10 May 2016
Amount $3.3184
11 May 2015
Amount $3.1761
12 May 2014
Amount $3.8328
9 May 2013
Amount $2.7700
10 May 2012
Amount $2.6500
16 May 2011
Amount $2.5000
20 May 2010
Amount $2.4000
23 Apr 2009
Amount $2.2000
16 May 2008
Amount $2.0700

Stock Splits

Split History

6 May 2022Stock Split
Ratio1005:1000

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about SNYNF

Which members of Congress have traded SNYNF?
1 member of Congress has disclosed 1 trade in Sanofi (SNYNF) under the STOCK Act: Peter Welch.
When was SNYNF most recently disclosed by Congress?
The most recent SNYNF disclosure was a purchase by Peter Welch on 21 January 2015.
What is the total disclosed congressional trading volume for SNYNF?
Members of Congress have disclosed approximately $8K in SNYNF purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in SNYNF?
This SNYNF page updates as soon as new STOCK Act disclosures are filed for Sanofi. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.